CTRI/2022/06/043374招募中未知
A double-blind, randomised, placebo-controlled clinical trial to evaluate the role of Vaginal Bacteriotherapy on IVF outcome in recurrent implantation failure (RIF) cases
Indira IVF Hospital Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Having two or more implantation failures after good embryo transfer(Gardenerâ??s grade 3/4/5/AA/AB/BA/BB).
- •2. Normal endometrial cavity evaluated by 3D ultrasound/ hysteroscopy
- •3. Normal parental karyotype
- •4. Subjects undergoing their IVF/ICSI cycle with own/ donor oocytes who will receivesingle embryo transfer of frozen blastocyst stage embryos (day 5/6) on an HRT cycle.
- •5. BMI: 18.5 - 30.0 kg/m2 (both inclusive).
- •6. Normal ovarian reserve (defined as AFC >= 8; AMH level >=1.2 ng/ml before the controlled ovarian stimulation (COS) initiation.
- •7. Negative serological tests for HIV, HBV, HCV, RPR.
- •8. Subjects who are willing to sign informed consent for participate in the study and willing to adhere to all protocol procedure.
排除标准
- •1. Uncontrolled diabetes, hypertension, heart disease or autoimmune disease.
- •2. Male partner with severe male factor infertility (total sperm count <5 million per ml).
- •3. Those who will require surgically retrieved sperm for ICSI.
- •4. Subjects who are intrauterine device (IUD) carriers in the last three months before embryo
- •5. Adenomyosis, unstable condition or any pathological finding affecting the endometrial cavity
- •6. Removal of myomas greater than 4 cm, within two months before embryo transfer
- •7. Salpingectomy/clipping for hydrosalpinx within one month before embryo transfer
- •8. Women who have received antibiotics (oral/ vaginal/parenteral) in the last one month before
- •embryo transfer.
研究者
相似试验
进行中（未招募）
1 期
A double-blind, randomised, placebo-controlled clinical study to evaluate the efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel, 1 and 2%, applied once daily for 12 weeks in patients with mild to moderate facial acne vulgarisfacial acne vulgarisMedDRA version: 19.0Level: LLTClassification code 10000519Term: Acne vulgarisSystem Organ Class: 100000004858EUCTR2016-000540-33-SKPPM Services S.A.144
进行中（未招募）
1 期
A double-blind, randomised, placebo-controlled clinical study to evaluate the efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel, 1 and 2%, applied once daily for 12 weeks in patients with mild to moderate facial acne vulgarisEUCTR2016-000540-33-HUPPM Services S.A.144
已完成
不适用
A double-blind, randomized, placebo-controlled clinical trial to investigate the effect of fermented milk containing Lactobacillus gasseri SBT2055 (LG2055) on fecal fat excretioJPRN-UMIN000015772ew drug research center, Inc.30
已完成
不适用
A double-blind, randomized, placebo-controlled clinical study to investigate the effect of the food containing the polyphenols in Ashitaba (Angelica keiskei)JPRN-UMIN000023988ew drug research center, Inc.40
已完成
不适用
A double-blind, randomized, placebo-controlled clinical trial to investigate the effect of the beverages containing plant extract (Ex.no. H24-0125)Healthy AdultJPRN-UMIN000021715QOL RD Co.,Ltd.160